Anondita Medicare Ltd IPO
Open Demat Account
Anondita Medicare Ltd IPO Details
Details
| Total Shares Offered | Offer to Public | Retail Max (Shares) | Pre Issue Promoters Holding | Exchange | Issue size |
|---|---|---|---|---|---|
| ₹ 47.93 L | TBA | ₹ 15.84 L | ₹ 111.61 L | NSE | ₹ 69.5 Cr |
| IPO Open Date | Close Date | Lot Size | Min Investment | Issue Type | Listing Date |
| 22 Aug, 25 | 26 Aug, 25 | 1000 | ₹ 1,37,000 | Book Building - SME | 01 Sep, 25 |
Anondita Medicare Ltd IPO Dates
Details
| Sector | Type |
|---|---|
| Sector | Miscellaneous |
| Sub Sector | NA |
| Issue Type | Book Building - SME |
Subscription Status
*Values are in Lakhs
| Investor Type | Subscription Times | Shares Offered* | Shares Bid* |
|---|---|---|---|
| QIB | 61.4x | 2258000 | 138648000 |
| NII | 532.25x | 681000 | 362463000 |
| Retail | 286.77x | 1584000 | 454242000 |
| Employee | 0x | 0 | 0 |
| Total | 199.32x | 4793000 | 955353000 |
Subscription Status
Investor Type
QIB
NII
Retail
Employee
Total
*Values are in Lakhs
Anondita Medicare Ltd Financial Status
Income Statement
Balance Sheet
| Particulars (in Rs. Crores) | FY23 | FY22 | FY21 |
|---|---|---|---|
| Revenue from operations | 76.99 | 0.00 | TBA |
| EBITDA | 16.27 | 0.00 | TBA |
| PAT | 10.80 | 0.00 | TBA |
| Total Assets | 40.57 | 0.10 | TBA |
| Share Capital | 13.29 | 0.10 | TBA |
| Total Borrowings | 40.87 | 0.07 | TBA |
| Operating Activities (Net Cash) | 11.72 | 0.00 | TBA |
| Investing Activities (Net Cash) | -2.98 | 0.00 | TBA |
| Financing Activities (Net Cash) | 40.87 | 0.07 | TBA |
| Net Cashflow | 0.26 | 0.03 | TBA |
Particulars (in Rs. Crores)
Revenue from operations
EBITDA
PAT
Total Assets
Share Capital
Total Borrowings
Operating Activities (Net Cash)
Investing Activities (Net Cash)
Financing Activities (Net Cash)
Net Cashflow
About Anondita Medicare Ltd
Our Company was incorporated as a public limited company with the name of Anondita Medicare Limited under the Companies Act, 2013 vide certificate of incorporation dated March 12, 2024, issued by Registrar of Companies, Central Registration Centre, bearing CIN U22193DL2024PLC428183. Prior to this, the business of the company was run by our current promoter, Mr. Anupam Ghosh, as a sole proprietorship under the name of Anondita Healthcare. Further, the entire business of Anondita Healthcare, including all assets and liabilities, was transferred to our company, Anondita Medicare Limited, vide Business Transfer Agreement dated April 01, 2024.
The global condom market has demonstrated robust growth through 2024-2025, reaching a valuation of approximately $14.3 billion in 2025. Market projections indicate continued expansion, with expectations of reaching $30.6 billion by 2034, representing a compound annual growth rate (CAGR) of 8.6% over the forecast period. The Indian condom market has demonstrated exceptional growth through 2024, reaching a valuation of approximately USD 245 million, representing year-on-year growth of 8.4%. Market projections indicate continued robust expansion, with expectations of reaching USD 410 million by 2030, reflecting a compound annual growth rate (CAGR) of 8.9% over the forecast period.
Our Company is a manufacturer of male condoms with a variety of flavors, with our flagship product marketed and sold under the brand COBRA. We have an installed production capacity of nearly 562 million condoms per annum, as per certificate issued by JP Sood, Chartered Engineer, dated June 04, 2025. Further, to follow sustainable production practices, our company uses CNG as a clean, environmentally friendly manufacturing fuel for its manufacturing plant situated at Sector 80, Noida, Uttar Pradesh.
Peer Comparison:
- Anondita Medicare Limited
- Cupid Limited
Anondita Medicare Ltd IPO Key Points
Strengths
- Production capabilities.
- Experienced management team and a motivated and efficient work force.
- Cordial relations with our consumers.
- Quality assurance and control.
Risk
- The Company had negative cash flows from its operating, investing and financing activities in the past and may continue to have negative cash flows in the future. Sustained negative cash flow could impact the company growth and business.
- The company depends on its top 10 customers for a significant portion of the company revenues. The loss of a major customer or significant reduction in demand from any of its major customers may adversely affect the company business, financial condition, results of operations and prospects.
- The Company derives a significant portion of its revenue from government contracts and tenders for the supply of condoms under various public health initiatives. Participation in these tenders is subject to stringent regulatory compliance, quality standards, and other eligibility criteria. Any failures to meet the requirements enlisted in these tenders may result in the Company being debarred or disqualified from participating in future government tenders, which could have a material adverse effect on the company business, financial condition, and results of operations.
Strategy
- Expanding Global Reach.
- UN Qualification and Export Launch.
- Introducing newer technology and automating manual processes.
- Launching new product lines and unique products.
- Production capabilities.
- Experienced management team and a motivated and efficient work force.
- Cordial relations with our consumers.
- Quality assurance and control.
How To Apply for Anondita Medicare Ltd IPO Online?
Step 1:
Log in to the BlinkX stock market app and click ‘IPO’ in the Xplore section.
Step 2:
From the list of open IPOs, select the IPO you want to invest.
Step 3:
Go through the IPO details like lot size, price band, about the company, etc.
Step 4:
Click ‘Apply IPO’ to apply and enter the number of lots and bidding price along with your UPI ID.
Step 5:
Confirm your bid and accept the payment mandate sent to your UPI App for completing the IPO application.
